These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2181434)

  • 1. Using a population-based cancer registry for recruitment in a pilot cancer control study.
    Newcomb PA; Love RR; Phillips JL; Buckmaster BJ
    Prev Med; 1990 Jan; 19(1):61-5. PubMed ID: 2181434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wisconsin Tamoxifen Study: toxicity in node-negative postmenopausal women.
    Love RR
    Cancer Invest; 1988; 6(5):601-5. PubMed ID: 3063340
    [No Abstract]   [Full Text] [Related]  

  • 3. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
    Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
    Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design issues for a breast cancer chemoprevention trial.
    DeMets DL; Newcomb PA; Carey P
    Prev Med; 1991 Jan; 20(1):101-8. PubMed ID: 2008419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
    Forbes JF; Sestak I; Howell A; Bonanni B; Bundred N; Levy C; von Minckwitz G; Eiermann W; Neven P; Stierer M; Holcombe C; Coleman RE; Jones L; Ellis I; Cuzick J;
    Lancet; 2016 Feb; 387(10021):866-73. PubMed ID: 26686313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial.
    Daly M; Seay J; Balshem A; Lerman C; Engstrom P
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):413-6. PubMed ID: 1305474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.
    Fisher B; Costantino J; Redmond C; Poisson R; Bowman D; Couture J; Dimitrov NV; Wolmark N; Wickerham DL; Fisher ER
    N Engl J Med; 1989 Feb; 320(8):479-84. PubMed ID: 2644532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wisconsin Spine Outcome Study-Pilot: preliminary data.
    Agrawal BM; Brooks NP; Resnick DK
    Neurosurg Focus; 2012 Jul; 33(1):E15. PubMed ID: 22746232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    Kroiss R; Fentiman IS; Helmond FA; Rymer J; Foidart JM; Bundred N; Mol-Arts M; Kubista E
    BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
    Veronesi U; Maisonneuve P; Costa A; Sacchini V; Maltoni C; Robertson C; Rotmensz N; Boyle P
    Lancet; 1998 Jul; 352(9122):93-7. PubMed ID: 9672273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
    Sestak I; Cuzick J; Sapunar F; Eastell R; Forbes JF; Bianco AR; Buzdar AU;
    Lancet Oncol; 2008 Sep; 9(9):866-72. PubMed ID: 18703382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer.
    Cummings FJ; Gray R; Davis TE; Tormey DC; Harris JE; Falkson GG; Arseneau J
    NCI Monogr; 1986; (1):119-23. PubMed ID: 3534584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
    Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J
    Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group.
    Rutqvist LE; Mattsson A
    J Natl Cancer Inst; 1993 Sep; 85(17):1398-406. PubMed ID: 8350363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of breast cancer.
    Powles TJ; Hardy JR; Ashley SE; Cosgrove D; Davey JB; Dowsett M; McKinna A; Nash AG; Rundle SK; Sinnett HD
    Breast Cancer Res Treat; 1989 Oct; 14(1):23-31. PubMed ID: 2690969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.